Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B

NCT01386528 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

13

Enrollment

INDUSTRY

Sponsor class

Conditions

Congenital Bleeding Disorder
Haemophilia B

Interventions

DRUG: nonacog beta pegol

Sponsor

Novo Nordisk A/S